Together, these results showed that myricetin treatment induced hepatic M2 macrophage polarization in CDAHFD-induced NASH and immunosuppressive genes (IL10 and CD163). The gene discussed is CD163; the disease is metabolic dysfunction-associated steatohepatitis.